Infliximab: lack of efficacy on perforating complications in Crohn's disease.
Miehsler W, Reinisch W, Kazemi-Shirazi L, Dejaco C, Novacek G, Ferenci P, Herbst F, Karner J, Téleky B, Schober E, Vogelsang H.
Miehsler W, et al. Among authors: herbst f.
Inflamm Bowel Dis. 2004 Jan;10(1):36-40. doi: 10.1097/00054725-200401000-00006.
Inflamm Bowel Dis. 2004.
PMID: 15058525